St. Michael's Hospital is a teaching hospital and medical centre in Toronto, Ontario, Canada. It was established by the Sisters of St. Joseph in 1892, with the founding goal of taking care of the sick and poor of Toronto's inner city.

There are 463 beds in Unity Health Toronto - St. Michael's Hospital.

During the past decade, Unity Health Toronto - St. Michael's Hospital conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 2 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 2 clinical trials were completed. i.e. 9.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Unity Health Toronto - St. Michael's Hospital" #1 sponsor was "Unity Health Toronto" with 13 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "The Hospital for Sick Children" with 2 trials sponsored, "Atara Biotherapeutics" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Unity Health Toronto - St. Michael's Hospital" #1 collaborator was "Berry Consultants" with 2 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "University of Calgary" with 2 trials as a collaborator, "Ascension Providence Rochester Hospital" with 1 trials as a collaborator and "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator. Other collaborators include 40 different institutions and companies that were collaborators in the rest 50 trials.

According to Clinical.Site data, the most researched conditions in "Unity Health Toronto - St. Michael's Hospital" are "ARDS" (1 trials), "Acetabular Fracture" (1 trials), "Airway Extubation" (1 trials), "Aortic Valve Replacement" (1 trials) and "Aortic Valve Stenosis" (1 trials). Many other conditions were trialed in "Unity Health Toronto - St. Michael's Hospital" in a lesser frequency.

Most popular intervention types in "Unity Health Toronto - St. Michael's Hospital" are "Drug" (13 trials), "Other" (9 trials), "Device" (5 trials), "Procedure" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Aflibercept" (2 trials), "Faricimab" (2 trials), "Sham Procedure" (2 trials) and "ADM/MDM hip" (1 trials). Other intervention names were less common.

The vast majority of trials in "Unity Health Toronto - St. Michael's Hospital" are 28 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Unity Health Toronto - St. Michael's Hospital". 3 are not yet recruiting, 13 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Unity Health Toronto - St. Michael's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Unity Health Toronto - St. Michael's Hospital, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 10 trials that are defined as “Not Applicable".